---
schema_version: "secwatch.filing_event.v1"
accession: "0001641489-23-000043"
form_type: "8-K"
ticker: "VTVT"
cik: "0001641489"
company_name: "vTv Therapeutics Inc."
filed_at: "2023-06-26T23:59:59+00:00"
generated_at: "2026-06-13T17:04:41.201490+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# vTv Therapeutics receives Nasdaq delisting notice; appeals, hearing set for Aug 17, 2023

## Summary
- Received delisting notice on June 21, 2023 for failure to regain compliance with minimum bid price rule.
- Nasdaq to suspend trading June 30, 2023 unless appeal filed; company appealed on June 22, staying suspension.
- Hearing before Nasdaq Hearings Panel scheduled for August 17, 2023; company to submit compliance plan.
- No assurance of regaining compliance; expedited review questionnaire also submitted.

## SEC filing metadata
- accession: 0001641489-23-000043
- form_type: 8-K
- ticker: VTVT
- cik: 0001641489
- company_name: vTv Therapeutics Inc.
- filed_at: 2023-06-26T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641489/000164148923000043/0001641489-23-000043-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641489/000164148923000043/vtvt-20230621.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641489-23-000043
- JSON: https://secwatch.observer/filing/0001641489-23-000043.json
- Plain text: https://secwatch.observer/filing/0001641489-23-000043.txt

## Key facts
- Listing & Compliance Notices
  vTv Therapeutics Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: June 21, 2023, vTv Therapeutics, Inc. (the “Company”) received a notice (the “Delisting Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) informing the Company that Nasdaq has determined the Company did not regain compliance with the minimum closing bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Rule”) by June 20, 2023, the deadline to regain compliance with the Rule pursuant to the notice the Company received from Nasdaq on December 22, 2022 (the “Extension Notice”), and therefore the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1641489/000164148923000043/0001641489-23-000043-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.